# Siegfried Hameln GmbH – FDA Inspection, Apr 24, 2018

Source: https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/e042aba9-c4b7-422c-b3eb-1a852022bb80
Source feed: FDA_Inspections

> FDA inspection 1050123 of Siegfried Hameln GmbH, April 24, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1050123
- Company Name: Siegfried Hameln GmbH
- Inspection Date: 2018-04-24
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1203347 - 2022-09-01
- FDA Inspection 987428 - 2016-07-01
- [FDA Inspection 887446 - 2014-07-25](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/098b0d0c-6d3f-4682-8290-157ece943b50)
- [FDA Inspection 786813 - 2012-06-14](https://www.keypedia.com/records/fda_inspections/siegfried-hameln-gmbh/ee325421-5a50-4446-ab22-7f225fce421f)
- FDA Inspection 637807 - 2009-11-09

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)

Company: https://www.keypedia.com/companies/siegfried-hameln-gmbh/f6010d3b-48cd-40df-ad2f-b13fa57fca0b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c